How should I taper off Ambien (zolpidem)?

Slow taper essential despite marketing of zolpidem as "non-habit-forming." Crossover to a longer-acting benzodiazepine (diazepam) for taper is sometimes used. Compounded liquid useful at low end. Treat zolpidem withdrawal with the same care as benzodiazepine withdrawal. Hyperbolic taper. Manage rebound insomnia behaviorally where possible — adding another sedative often just shifts dependence.

How long does Ambien withdrawal last?

Ambien withdrawal typically begins 1-3 days after stopping (often within 24 hours given short half-life), peaks around 3-7 days, and resolves within 2-6 weeks for most. Sleep architecture changes can persist 1-3 months; some report long-term sleep dysregulation

Forums/Drug Profiles/

Ambien Tapering Guide

zolpidem

Z-drugFDA 1992

Go to Community Forum

Boxed Warning

Complex sleep behaviors (sleep-driving, sleep-walking, sleep-eating) — discontinue immediately if any episode occurs. Risk of next-day impairment, especially in women and at higher doses.

Overview

Zolpidem is a non-benzodiazepine "Z-drug" hypnotic for short-term insomnia. Despite the marketing distinction from benzos, it acts on the same GABA-A receptor system, produces tolerance, dependence, and withdrawal, and carries an FDA boxed warning for complex sleep behaviors.

Common Doses

5mg, 10mg tablets (IR); 6.25mg, 12.5mg tablets (CR); 1.75mg, 3.5mg sublingual (Edluar/Intermezzo)

Formulations

Tablets (IR): 5mg, 10mg; Tablets (CR): 6.25mg, 12.5mg; Sublingual (Edluar): 5mg, 10mg; Sublingual (Intermezzo, middle-of-night): 1.75mg, 3.5mg; Oral spray (Zolpimist)

Pregnancy

Category C

Mechanism of Action

Selective agonist at the alpha-1 subunit of the GABA-A receptor. Functionally similar to benzodiazepines for sedation but with less anxiolytic and muscle-relaxant effect.

Taper Notes

Slow taper essential despite marketing of zolpidem as "non-habit-forming." Crossover to a longer-acting benzodiazepine (diazepam) for taper is sometimes used. Compounded liquid useful at low end.

Hyperbolic Tapering Guidance

Treat zolpidem withdrawal with the same care as benzodiazepine withdrawal. Hyperbolic taper. Manage rebound insomnia behaviorally where possible — adding another sedative often just shifts dependence.

Summary written by TaperCommunity, informed by the Maudsley Deprescribing Guidelines (Horowitz & Taylor) and related literature — see Sources & References below. Not affiliated with or endorsed by the Maudsley.

Withdrawal Timeline

⏱Onset

1-3 days after stopping (often within 24 hours given short half-life)

📈Peak Severity

3-7 days

📉Resolution

2-6 weeks for most

⚠️Protracted Risk

Sleep architecture changes can persist 1-3 months; some report long-term sleep dysregulation

Common Withdrawal Symptoms

rebound insomnia (often severe)anxietytremorsweatingGI upsetirritabilityseizures (rare, with high-dose long-term use)hallucinations

Interactions & Safety

Drug Interactions

CNS depressants (alcohol, opioids, benzos, gabapentinoids) — additive respiratory depression
Strong CYP3A4 inhibitors (ketoconazole, ritonavir) — increased exposure
Strong CYP3A4 inducers — reduced efficacy

Contraindications

Prior history of complex sleep behaviors on zolpidem (boxed warning)
Severe hepatic impairment
Sleep apnea (relative — risk of worsening)

Toxicity

Respiratory depression with alcohol or opioids. Complex sleep behaviors (sleep-driving, sleep-eating, sleep-walking) can occur even at therapeutic doses. Anterograde amnesia.

Pharmacokinetics

ADME Profile

Metabolism

Hepatic via CYP3A4 (major) and CYP2C9, CYP1A2.

Elimination

Renal as inactive metabolites.

Protein Binding

~92%

Need a clinician who understands tapering?

Browse our map of deprescribing-informed providers worldwide.

Find a Deprescriber

Other Drug Profiles

Lexapro

escitalopram — SSRI

Zoloft

sertraline — SSRI

Paxil

paroxetine — SSRI

Prozac

fluoxetine — SSRI

Sources & References

Ambien (zolpidem) information on this page is sourced from peer-reviewed research, regulatory bodies, clinical guidelines, and patient-advocacy organizations.

Encyclopedic & chemical databases

Neutral, high-authority entity references.

Regulatory sources

Official prescribing information and safety notices.

FDA prescribing information — Ambien (zolpidem)

Peer-reviewed research

Primary literature cited in this taper guide.

Buscemi N, Vandermeer B, Friesen C, et al. 2007 — The efficacy and safety of drug treatments for chronic insomnia in adults (Journal of General Internal Medicine)
Lader M 2014 — Benzodiazepine harm: how can it be reduced? (British Journal of Clinical Pharmacology)
Horowitz MA, Taylor D 2019 — Tapering of SSRI treatment to mitigate withdrawal symptoms (hyperbolic taper) (The Lancet Psychiatry)

Clinical guidelines

Evidence-based deprescribing and prescribing standards.

Deprescribing-specific resources

Clinician-facing references on tapering protocols.

Deprescribing.org — benzodiazepine receptor agonist algorithm — Evidence-based Z-drug / BZRA deprescribing algorithm
British National Formulary (BNF) — UK formulary guidance on hypnotic prescribing
Cochrane Library — Z-drug reviews — Systematic reviews of hypnotic efficacy and safety

Patient-advocacy & lived-experience

Long-running communities documenting withdrawal experience.

BenzoBuddies — Z-drug section — Peer-support community covering Z-drug tapering
Benzodiazepine Information Coalition — Education on benzodiazepine-receptor-agonist dependence
Inner Compass Initiative — Withdrawal Project — Peer-led psychiatric drug withdrawal resources
Mad in America — sleep medication archive — Journalism on hypnotic prescribing and withdrawal

TaperCommunity does not provide medical advice. Always consult a qualified prescriber before adjusting psychiatric medication.